Ortoma Plan™ included in a new research study

Published December 22, 2014

Ortoma preoperative planning system for measurement of anatomic data in three dimensions during implant surgery will be part of another research study at Skåne University Hospital in Lund. Ethical approval has now been granted to conduct the study in which the planning system Ortoma Plan ™ are included.

The study will enroll 30 patients and starts during the first quarter of 2015. An installation of a full-scale Ortoma Plan ™ is installed and the system will in the study will be used for surveying and planning of patient facing hip replacement surgery.

“Ortoma planning system Ortoma Plan ™ are included in a study again shows the interest to implement 3D measurement of anatomical measurement data at hip operations,” said company CEO Bertil G. Larsson.

For further information please contact:

Bertil G. Larsson, CEO
Telephone: +46 (0) 702 99 75 10
E-mail: [email protected]

About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company’s surgical system, Ortoma Treatment Solution™ (OTS) is to enable surgeons to accurately measure and plan 3D surgery for the placement of joint implants, and during surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for implants. OTS is a system that is easily integrated into the processes and routines currently used in surgery, thereby increasing efficiency. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden, around 42,000 surgical procedures were performed last year, involving hip, knee or spinal surgery. Ortoma’s B shares are listed on Nasdaq First North Growth Market Stockholm.